137 related articles for article (PubMed ID: 26171022)
1. Expression of the estrogen receptor α, progesterone receptor and epidermal growth factor receptor in papillary thyroid carcinoma tissues.
Chen D; Qi W; Zhang P; Guan H; Wang L
Oncol Lett; 2015 Jul; 10(1):317-320. PubMed ID: 26171022
[TBL] [Abstract][Full Text] [Related]
2. Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea.
Ahn HY; Song RY; Ahn HS; Kim HS
Cancer Res Treat; 2021 Oct; 53(4):1204-1212. PubMed ID: 33592140
[TBL] [Abstract][Full Text] [Related]
3. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
[TBL] [Abstract][Full Text] [Related]
4. Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiter.
Dong W; Li J; Huang Y; Zhang H; Shan Z; Teng W
Med Sci Monit; 2012 Sep; 18(9):BR351-5. PubMed ID: 22936184
[TBL] [Abstract][Full Text] [Related]
5. Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas.
Dai YJ; Qiu YB; Jiang R; Xu M; Zhao L; Chen GG; Liu ZM
Sci Rep; 2017 Sep; 7(1):12279. PubMed ID: 28947799
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Expression of Estrogen Receptor-α and Progesterone Receptor in Patients with Papillary Thyroid Cancer.
Sturniolo G; Zafon C; Moleti M; Castellví J; Vermiglio F; Mesa J
Eur Thyroid J; 2016 Dec; 5(4):224-230. PubMed ID: 28101486
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms.
Liu J; Chen G; Meng XY; Liu ZH; Dong S
Pathol Res Pract; 2014 Dec; 210(12):830-5. PubMed ID: 25305147
[TBL] [Abstract][Full Text] [Related]
8. Expression of estrogen and progesterone receptors in papillary thyroid carcinoma.
Jalali-Nadoushan MR; Amirtouri R; Davati A; Askari S; Siadati S
Caspian J Intern Med; 2016; 7(3):183-187. PubMed ID: 27757203
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma.
Eldien MMS; Abdou AG; Rageh T; Abdelrazek E; Elkholy E
Ecancermedicalscience; 2017; 11():748. PubMed ID: 28717394
[TBL] [Abstract][Full Text] [Related]
10. Distribution and Prognostic Significance of Estrogen Receptor
Mishra A; Kumari N; Jha CK; Bichoo RA; Mishra SK; Krishnani N; Mishra SK
J Thyroid Res; 2020; 2020():6935724. PubMed ID: 32426104
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
12. Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer.
Vannucchi G; De Leo S; Perrino M; Rossi S; Tosi D; Cirello V; Colombo C; Bulfamante G; Vicentini L; Fugazzola L
Eur J Endocrinol; 2015 Jul; 173(1):29-36. PubMed ID: 25862786
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features.
Yavropoulou MP; Panagiotou G; Topouridou K; Karayannopoulou G; Koletsa T; Zarampoukas T; Goropoulos A; Chatzaki E; Yovos JG; Pazaitou-Panayiotou K
J Endocrinol Invest; 2017 Dec; 40(12):1327-1335. PubMed ID: 28589382
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study of epidermal growth factor receptor and estrogen receptor in human thyroid tumors].
Yane K; Tanaka O; Miyahara H; Matsunaga T; Kitahori Y; Hiasa Y
Nihon Jibiinkoka Gakkai Kaiho; 1993 May; 96(5):787-90. PubMed ID: 8315535
[TBL] [Abstract][Full Text] [Related]
16. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
17. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
[TBL] [Abstract][Full Text] [Related]
18. PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.
Qiu YB; Liao LY; Jiang R; Xu M; Xu LW; Chen GG; Liu ZM
Sci Rep; 2019 Jan; 9(1):1032. PubMed ID: 30705367
[TBL] [Abstract][Full Text] [Related]
19. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.
Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H
J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the Na(+)/I(-) symporter protein in thyroid cancer and adjacent normal and nodular goiter tissues.
Wang S; Liang J; Lin Y; Yao R
Oncol Lett; 2013 Jan; 5(1):368-372. PubMed ID: 23255951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
